PDCD1 and melanoma: Moreover, by analyzing tumor-infiltrating CD8+ T cells in melanoma patients treated with PD-1 or CTLA4 checkpoint immunotherapy (36), we found that T cells from nonresponders showed higher enrichment of lipid peroxidation and ferroptosis activation genes compared with responders (Supplemental Figure 4, D and E).